
4179. reduced estriol excretion patients 
breast cancer prior endocrine 
therapy 
urinary quotient estriol/estrone + 
estradiol-17b(eq) measured chemically 
women without breast cancer, in- 
dex ratio noncarcinogenic impeded es- 
trogens mammary carcinogenic estrogens.  
34 controls, median eq 1.3 1.2 
menopause, 21% patients sub- 
normal.  26 breast cancer patients without endo- 
crine treatment recent surgery, median eq 
0.5 0.8 respectively, 62% pa- 
tients subnormal.  major surgery hormo- 
nal therapy, 23% 53 patients subnor- 
mal, remissions observed unless eq 
rose toward normal.  matching 24 controls 
patients pairs age ovarian status 
wilcoxon test indicated decreased eq ex- 
creted untreated cancer significant 
0.2% confidence level.  marked increase eq 
induced castration androgen, estrogen, 
corticosteroid therapy suggests normaliza- 
tion precancerous metabolic imbalance be- 
tween impeded active estrogens derived 
ovarian adrenocortical sources contributed 
arrested growth estradiol-dependent metastases. 
